Literature DB >> 29718591

Glomerular crescents are associated with worse graft outcome in allograft IgA nephropathy.

Sehoon Park1,2, Chung Hee Baek3, Hyunjeong Cho4, Mi-Yeon Yu5, Yong Chul Kim5, Heounjeong Go6, Young Hoon Kim7, Jung Pyo Lee5,8, Sang Il Min9, Jongwon Ha9, Kyung Chul Moon10, Yon Su Kim1,2,5, Curie Ahn1,5, Su-Kil Park3, Hajeong Lee1,5.   

Abstract

The prognosis of patients with allograft IgA nephropathy (IgAN) requires further investigation. We performed a bicenter retrospective cohort study on kidney transplant recipients diagnosed with IgAN in allograft biopsy. Recipients without allograft IgAN but with known IgAN before transplantation were included as the control group. We investigated the associations between clinicopathological characteristics, including allograft crescents, and the risk of death-censored graft failure. In total, 1256 IgAN patients in both pre- and posttransplant stages were included. Among them, 559 were diagnosed with allograft IgAN, which was a time-dependent risk factor for worse prognosis (adjusted hazard ratio = 5.009 [3.610-6.951]; P < .001) during a median of 8.1 years of follow-up. Of the patients with allograft IgAN, 88 (15.9%) had glomerular crescents, including 40 patients (7.2%) with >10% crescent formation in the total biopsied glomeruli. The presence of glomerular crescents in IgAN was associated with a worse graft prognosis, and the association was still valid with the C scores of the current Oxford classification. In conclusion, allograft IgAN is a time-dependent event and is associated with worse graft outcomes. The pathological characteristics of allograft, particularly the degree of glomerular crescent formation, may represent important risk factors for a poor prognosis.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; graft survival; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; pathology/histopathology

Mesh:

Year:  2018        PMID: 29718591     DOI: 10.1111/ajt.14908

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  4 in total

1.  Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.

Authors:  Jingjing Chen; Hui Xu; Zhangzhe Peng; Lizhen Lin; Cuifang Li; Xuejing Zhu; Shao Liu
Journal:  Clin Exp Nephrol       Date:  2019-10-11       Impact factor: 2.801

2.  Possible beneficial association between renin-angiotensin-aldosterone-system blockade usage and graft prognosis in allograft IgA nephropathy: a retrospective cohort study.

Authors:  Sehoon Park; Chung Hee Baek; Heounjeong Go; Young Hoon Kim; Sang-Il Min; Jongwon Ha; Yong Chul Kim; Jung Pyo Lee; Yon Su Kim; Kyung Chul Moon; Su-Kil Park; Hajeong Lee
Journal:  BMC Nephrol       Date:  2019-09-11       Impact factor: 2.388

3.  Sustained remission of rapidly progressive post-transplant immunoglobulin A nephropathy by treatment with tonsillectomy following steroid pulse therapy: a case report.

Authors:  Aoi Yamashiro; Muneharu Yamada; Yu Kihara; Osamu Konno; Hitoshi Iwamoto; Takashi Oda
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

Review 4.  The glomerular crescent: triggers, evolution, resolution, and implications for therapy.

Authors:  Lidia Anguiano; Renate Kain; Hans-Joachim Anders
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-05       Impact factor: 3.416

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.